Paternabio
1 known investors
Paterna Biosciences develops in vitro spermatogenesis (IVS) technology that drives adult testicular stem cells to develop into optimized sperm, aiming to treat male infertility and improve IVF success rates. The company targets couples facing infertility and the broader male reproductive health field, where roughly half of failed IVF cycles involve a male factor.
BiotechDigital HealthFemTech